Peter Blanken

2.3k total citations
66 papers, 1.6k citations indexed

About

Peter Blanken is a scholar working on Epidemiology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Peter Blanken has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 19 papers in Psychiatry and Mental health and 18 papers in Clinical Psychology. Recurrent topics in Peter Blanken's work include Substance Abuse Treatment and Outcomes (29 papers), Schizophrenia research and treatment (16 papers) and Opioid Use Disorder Treatment (13 papers). Peter Blanken is often cited by papers focused on Substance Abuse Treatment and Outcomes (29 papers), Schizophrenia research and treatment (16 papers) and Opioid Use Disorder Treatment (13 papers). Peter Blanken collaborates with scholars based in Netherlands, United States and Germany. Peter Blanken's co-authors include Wim van den Brink, Vincent M. Hendriks, Jan M. van Ree, Ingmar H. A. Franken, Marlies A.E. Marissen, Andrew J. Waters, E. van der Schee, Marcel G. W. Dijkgraaf, Corianne A.J.M. de Borgie and Jean‐Paul Grund and has published in prestigious journals such as The Lancet, Scientific Reports and Addiction.

In The Last Decade

Peter Blanken

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Blanken Netherlands	21	671	467	315	291	263	66	1.6k
Alex Baldacchino United Kingdom	25	625 0.9×	651 1.4×	253 0.8×	530 1.8×	282 1.1×	111	2.2k
Vincent Laprévote France	20	372 0.6×	342 0.7×	269 0.9×	377 1.3×	326 1.2×	75	1.6k
Victoria R. Votaw United States	18	683 1.0×	401 0.9×	203 0.6×	466 1.6×	191 0.7×	51	1.8k
José Pérez de los Cobos Spain	19	605 0.9×	371 0.8×	334 1.1×	275 0.9×	139 0.5×	64	1.6k
Mélina Fatseas France	26	708 1.1×	567 1.2×	166 0.5×	588 2.0×	257 1.0×	91	2.0k
Steven L. Batki United States	28	902 1.3×	433 0.9×	524 1.7×	404 1.4×	149 0.6×	93	2.4k
Gerardo González United States	24	677 1.0×	338 0.7×	415 1.3×	330 1.1×	104 0.4×	101	1.9k
S. Kelly Avants United States	28	771 1.1×	265 0.6×	336 1.1×	449 1.5×	224 0.9×	61	2.3k
Karran A. Phillips United States	23	643 1.0×	391 0.8×	385 1.2×	163 0.6×	178 0.7×	62	1.9k
Jennifer R. Schroeder United States	24	520 0.8×	529 1.1×	147 0.5×	213 0.7×	95 0.4×	57	1.9k

Countries citing papers authored by Peter Blanken

Since Specialization

Citations

This map shows the geographic impact of Peter Blanken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Blanken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Blanken more than expected).

Fields of papers citing papers by Peter Blanken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Blanken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Blanken. The network helps show where Peter Blanken may publish in the future.

Co-authorship network of co-authors of Peter Blanken

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Blanken. A scholar is included among the top collaborators of Peter Blanken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Blanken. Peter Blanken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuferov, Vadim, Eduardo R. Butelman, Matthew Randesi, et al.. (2021). Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users. Neuropsychiatric Disease and Treatment. Volume 17. 659–670. 4 indexed citations

Goudriaan, Anna E., Peter Blanken, Dike van de Mheen, et al.. (2021). Youth in transition: Study protocol of a prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment. BMC Psychiatry. 21(1). 605–605. 4 indexed citations

Wierdsma, André I., et al.. (2018). Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial. BMC Research Notes. 11(1). 655–655. 7 indexed citations

Wierdsma, André I., et al.. (2017). Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial. The Lancet Psychiatry. 4(3). 199–207. 35 indexed citations

Randesi, Matthew, Wim van den Brink, Orna Levran, et al.. (2016). Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Drug and Alcohol Dependence. 168. 164–169. 13 indexed citations

Blanken, Peter, et al.. (2016). Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. Drug and Alcohol Dependence. 164. 55–63. 12 indexed citations

Blanken, Peter, Vincent M. Hendriks, Maarten W.J. Koeter, et al.. (2014). Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug and Alcohol Dependence. 145. 101–105. 24 indexed citations

Berg, Julia F. van den, et al.. (2014). Physical and Mental Health and Social Functioning in Older Alcohol-Dependent Inpatients: The Role of Age of Onset. European Addiction Research. 20(5). 226–232. 7 indexed citations

Blanken, Peter, et al.. (2013). [Multidimensional family therapy and cognitive behavioral therapy in adolescents with a cannabis use disorder: a randomised controlled study].. PubMed. 55(10). 747–59. 5 indexed citations

10.

Hendriks, Vincent M., E. van der Schee, & Peter Blanken. (2012). Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: Treatment effect moderators in a randomized controlled trial. Drug and Alcohol Dependence. 125(1-2). 119–126. 33 indexed citations

11.

Hendriks, Vincent M., E. van der Schee, & Peter Blanken. (2011). Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug and Alcohol Dependence. 119(1-2). 64–71. 74 indexed citations

12.

Blanken, Peter, Vincent M. Hendriks, Maarten W.J. Koeter, Jan M. van Ree, & Wim van den Brink. (2011). Craving and illicit heroin use among patients in heroin-assisted treatment. Drug and Alcohol Dependence. 120(1-3). 74–80. 19 indexed citations

13.

Blanken, Peter, Wim van den Brink, Vincent M. Hendriks, et al.. (2010). Heroin-assisted treatment in the Netherlands: History, findings, and international context. European Neuropsychopharmacology. 20. S105–S158. 51 indexed citations

14.

Marissen, Marlies A.E., Ingmar H. A. Franken, Peter Blanken, Wim van den Brink, & Vincent M. Hendriks. (2007). Cue Exposure Therapy for the Treatment of Opiate Addiction: Results of a Randomized Controlled Clinical Trial. Psychotherapy and Psychosomatics. 76(2). 97–105. 87 indexed citations

15.

Fischer, Benedikt, Eugenia Oviedo‐Joekes, Peter Blanken, et al.. (2007). Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics. Journal of Urban Health. 84(4). 552–562. 79 indexed citations

16.

Dijkgraaf, Marcel G. W., et al.. (2006). Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. Drug and Alcohol Dependence. 86(1). 84–90. 23 indexed citations

17.

Marissen, Marlies A.E., Ingmar H. A. Franken, Andrew J. Waters, et al.. (2006). Attentional bias predicts heroin relapse following treatment. Addiction. 101(9). 1306–1312. 217 indexed citations

18.

Dijkgraaf, Marcel G. W., et al.. (2005). Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ. 330(7503). 1297–1297. 103 indexed citations

19.

Grund, Jean‐Paul, et al.. (1992). Reaching the Unreached: Targeting Hidden IDU Populations with Clean Needles via Known User Groups. Journal of Psychoactive Drugs. 24(1). 41–47. 67 indexed citations

20.

Grund, Jean‐Paul, et al.. (1991). Drug Sharing and HIV Transmission Risks: The Practice of Frontloading in the Dutch Injecting Drug User Population. Journal of Psychoactive Drugs. 23(1). 1–10. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact